We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.
Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.
(Wall Street Journal) May 3, 2013 - The FDA approved J&J's Sedasys device, which sedates patients for certain medical tests without the need for an anesthesiologist.
read article (paid subscription required) 
(Reuters) May 6, 2013 - The Food and Drug Administration warned on Monday that using a shorter name for Roche's new breast cancer drug Kadcyla may lead to the treatment being confused with an older therapy and cause potential harm to patients.
read article 
(Bloomberg) May 5, 2013 - Just as Novartis AG’s best-selling medicines are losing patent protection, the company is poised to get a revenue boost from a U.S. program designed to speed life-saving therapies to patients with few treatment options.
read article 
(Wall Street Journal) May 3, 2013 - Researchers at an international conference on autism on Friday presented three new studies lending strength to the notion that environmental influences before birth may play a role in the risk for the condition.
read article (paid subscription required) 
(BloombergBusinessweek) May 2, 2013 - Two years ago, over objections from the hospital industry, the U.S. announced it would add data about “potentially life-threatening” mistakes made in hospitals to a website people can search to check on safety performance.
read article 
(Wall Street Journal) May 2, 2013 - Sen. Charles Grassley is expanding his investigation into how investors got advance word of a market-moving Medicare policy decision, a development that could shine a spotlight on the office of one of the senator's own colleagues.
read article (paid subscription required) 
(Reuters) May 3, 2013 - Is nanomedicine the next big thing? A growing number of top drug companies seem to think so.
read article 
(CNNMoney) May 1, 2013 - Amgen today announced that four individuals who are an inspiration and have made a difference for others affected by cancer have been selected as Breakaway from Cancer® Champions.
read article 
(Lincoln Journal Star) May 3, 2013 - A $323 million University of Nebraska Cancer Center will have a familiar name: Buffett.
read article 
(Yahoo! Finance) May 2, 2013 - Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases, today reported that Shire plc has concluded the collaboration with Acceleron on ACE-031 and related molecules.
read article 
(MedCity News) May 2, 2013 - One of the biggest frustrations cancer doctors have is feeling like they’re the only ones treating cancer, according to Nathaniel Turner, co-founder of cancer data analytics startup Flatiron Health.
read article 
(PEAC/IMF) May 2, 2013 - The Patients Equal Access Coalition (PEAC) commends Congressman Brian Higgins (NY-26th District) on the introduction of the Cancer Drug Coverage Parity Act, H.R. 1801 on April 26.
read press release 
(Houston Chronicle/SciGuy blog) May 2, 2013 - The University of Texas System regents hired Dr. Ron DePinho two years ago, in part, because of his expertise in drug development and commercialization.
read article 
(Toronto Star) May 2, 2013 - The agency says that in Canada, two cases of necrotizing fasciitis have been seen in people using Avastin and one of those cases was fatal.
read article 
(Johns Hopkins Medicine) May 2, 2013 - Blocking a single gene renders tumors less aggressive, Johns Hopkins researchers find.
read press release 
(Moffitt) May 1, 2013 - Moffitt Cancer Center and the University of South Florida have collaborated with researchers in China, the United Kingdom, the Netherlands and Germany to devise a new computational method for assessing lung cancer tumors using CT, PET or MRI diagnostic technologies.
read press release 
(U.S. News & World Report/HealthDay News) May 3, 2013 - The number of testicular cancer cases continues to climb slowly but steadily in the United States, according to new research.
read article 
(UNC Cancer Care) May 3, 2013 - Breast cancer brain metastases present a challenge to clinicians because there are few systemic therapies capable of crossing the blood-brain barrier to control the disease.
read press release 
(ASBrS) May 2, 2013 - Routine imaging studies conducted less than a year after a benign breast biopsy are an unnecessary drain on healthcare dollars.
read press release 
(ASBrS) May 2, 2013 - Women with cancer in one breast who choose a prophylactic mastectomy of their healthy breast risk unnecessary complications, according to a new study presented this week at the American Society of Breast Surgeons (ASBrS) Annual Meeting.
read press release 
(ASBrS) May 2, 2013 - Postmenopausal women aged 55 to 75 with early stage breast cancer can be safely treated with breast conservative surgery without post-operative radiation therapy, according to a double arm, prospective, randomized study presented this week at the American Society of Breast Surgeons (ASBrS) Annual Meeting.
read press release 
(Fred Hutchinson CRC) May 1, 2013 - Men with prostate cancer who take cholesterol-lowering drugs called statins are significantly less likely to die from their cancer than men who don’t take such medication, according to a study led by researchers at Fred Hutchinson Cancer Research Center.
read press release 
(Reuters) May 3, 2013 - Urologists fell in line with other doctor groups on Friday in recommending careful consideration and discussion when it comes to screening for prostate cancer, rather than a gung-ho approach.
read article 
(Huffington Post) May 2, 2013 - With cuts from sequestration forcing private cancer clinics to turn away Medicare patients, several fiscally conservative Republicans have joined Democrats in pushing the Obama administration to change policy.
read article 
(Reuters) May 2, 2013 - A panel of advisers to the U.S. health regulator unanimously recommended against approving Delcath Systems Inc's cancer therapy for a rare form of eye cancer that spreads to the liver, saying it was too risky.
read article 